MIAMI, NY, UNITED STATES, October 5, 2026 /EINPresswire.com/ — BioTissue, a leader in regenerative healing across the ocular surface disease continuum, today announced the appointment of Rocco Venezia, CPA, as Chief Financial Officer. Venezia succeeds longtime BioTissue CFO Mike Cornelius, who retires after 13 years of service to the company.

Venezia joins BioTissue from Intercept Pharmaceuticals, where he most recently served as Chief Financial Officer and led enterprise-wide finance operations, strategic planning, capital management, and financial transformation initiatives. During his 10-year tenure at Intercept, he progressed through several leadership roles, including Corporate Controller, before being named CFO.

Throughout his career, Venezia has led fundraising efforts exceeding $1.3 billion, supported IPO and M&A transactions, and partnered closely with executive leadership teams and boards to support sustainable growth and operational excellence. Prior to Intercept, he held finance and accounting leadership positions at Mallinckrodt Pharmaceuticals and KPMG. He earned a Bachelor of Science in Accounting from Kean University.

“Rocco brings a depth of financial and operational experience that will be incredibly valuable as BioTissue continues to grow,” said Ted Davis, President and CEO of BioTissue. “His perspective will help us continue building a strong, sustainable organization that can advance our mission of empowering eye care professionals and improving healing outcomes.”

“I’m excited to join BioTissue at such an important point in the company’s journey,” said Venezia. “BioTissue has built a strong foundation around improving outcomes for patients and eye care professionals, and I look forward to partnering with the team to help support the company’s continued growth and long-term success.”

For more information, visit BioTissue.com.

Wendy Boyce
McDougall Communications
email us here
+1 5857525805
Visit us on social media:
LinkedIn
Instagram
Facebook

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Media gallery

About The Author
Written By: EIN Presswire